The summer was one of the most profitable on record for us, too.  In fact, since May, here are just some of the wins collected by subscribers:

  • Bovie Medical Corporation (BVX) up 159%
  • Rigel Pharmaceuticals (RIGL) up 29%
  • Goldfield Corporation (GV) up 106%
  • MeetMe Inc. (MEET) up 135%
  • Adverum Biotechnologies (ADVM) up 37%
  • Groupon Inc. (GRPN) up 77%
  • Supreme Industries (STS) up 33%
  • Fate Therapeutics (FATE) up 82%
  • Trio-Tech International (TRT) up 26%

In the May 2016 issue of The Cheap Investor, we recommended a buy on BVX – a medical device and supply maker -- at just $1.87 a share. 

At the time of recommendation, the company was increasing revenues and reducing its net loss but was stuck at a 52-week-low. 

The stock has since jumped to $4.84.

Bovie Medical (BVX)

Insiders seem pleased with the stock, too.  Chief Commercialization Officer (CCO) bought 90,750 shares at an average price of $3.30 for $299,475.

Better yet, the company just received 501(k) clearance from the FDA for its PlazXact product for the cutting, vaporization and coagulation of soft tissue during arthroscopic surgical procedures. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment